False
April 30, 2026
Illumina
In this webinar, Dr. Gang Zheng MD, PhD, will share experience from the Mayo Clinic laboratory, how the lab approaches liquid biopsy and recent implementation data of a liquid biopsy assay to enable comprehensive genomic profiling (CGP).
11:00 am - 12:00 pm GMT-4 min
March 18, 2026
Illumina
Liquid biopsy is increasingly being adopted to support tumour profiling across cancer pathways, particularly where tissue is limited or results are needed quickly.
11:00 am - 12:00 pm GMT-4 min
March 12, 2026
Illumina
Standard-of-care (SOC) genomic testing in acute myeloid leukemia (AML) has historically resulted in fragmented, incomplete genomic profiles that mask clinically significant biology.
11:00 am - 12:00 pm GMT-4 min
December 3, 2025
Thermo Fisher Scientific
In this webinar, you’ll see real time-and-motion data comparing two NGS workflows (amplicon based Oncomine Dx Express Test* and hybrid capture based NGS workflow) for routine precision oncology,
6:00 pm - 7:00 pm GMT min
November 12, 2025
GE Healthcare
Pathology is changing. And not just a little—it’s undergoing a transformation that will define the future of healthcare.
1:00 pm - 2:00 pm GMT min
November 6, 2025
Thermo Fisher Scientific
Watch our illuminating on-demand webinar titled "Advancing biomarker detection in lymphoid malignancies: Insights from leading scientists," featuring two of the foremost authorities in haemato-oncology.
October 23, 2025
Thermo Fisher Scientific
Rapid comprehensive genomic profiling (CGP) is crucial for gaining important insights when timely results matter.
4:00 pm - 5:00 pm BST min
September 23, 2025
Illumina
TruSight™ Oncology 500 v2 (TSO500v2) is an updated next-generation sequencing (NGS) assay designed to enable laboratories with in-house comprehensive genomic profiling (CGP) from formalin-fixed, paraffin-embedded (FFPE) tissue samples.
12:00 pm - 1:00 pm GMT-4 min
September 3, 2025
Qiagen
Somatic mutations are key drivers in tumorigenesis and serve as critical diagnostic, prognostic, and predictive biomarkers.
10:00 am - 11:00 am GMT-4 min
December 10, 2024
Thermo Fisher Scientific
Evaluation of the Oncomine Comprehensive Assay Plus for comprehensive genomic profiling including homologous recombination deficiency assessment.
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False